Ontology highlight
ABSTRACT: Background/aim
Almost 15% of patients with sporadic primary hyperparathyroidism (sPHPT) present with multiple gland disease (MGD). The aim of this study was to investigate the potential role of two polymorphisms of the hsa-miR-30e, in sPHPT tumorigenesis.Patients and methods
One-hundred twenty sPHPT patients, 77 presenting a single adenoma and 43 with MGD, and 54 healthy controls were genotyped. The SNPs were identified using the allele-specific PCR methodology, while the hsa-miR-30e expression was analyzed by real-time quantitative reverse transcriptase PCR.Results
Hsa-miR-30e expression was found to be significantly higher in patients with MGD compared to patients with single adenomas (p=0.0019), but no differences were found regarding specific genotype carriers. The genotype frequencies for ss178077483 and rs7556088 were significantly different between patients and healthy controls.Conclusion
Although the polymorphisms cannot be used as biomarkers for the differential diagnosis of MGD, hsa-miR-30e expression could potentially serve as a biomarker for this purpose.
SUBMITTER: Mizamtsidi M
PROVIDER: S-EPMC6689336 | biostudies-literature | 2019 Jul-Aug
REPOSITORIES: biostudies-literature
Mizamtsidi Maria M Nastos Konstantinos K Palazzo Fausto F Constantinides Vasilis V Dina Roberto R Farenden Megan M Mastorakos George G Vassiliou Ioannis I Gazouli Maria M
In vivo (Athens, Greece) 20190701 4
<h4>Background/aim</h4>Almost 15% of patients with sporadic primary hyperparathyroidism (sPHPT) present with multiple gland disease (MGD). The aim of this study was to investigate the potential role of two polymorphisms of the hsa-miR-30e, in sPHPT tumorigenesis.<h4>Patients and methods</h4>One-hundred twenty sPHPT patients, 77 presenting a single adenoma and 43 with MGD, and 54 healthy controls were genotyped. The SNPs were identified using the allele-specific PCR methodology, while the hsa-miR ...[more]